Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716626 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716640 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716766 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL11835782 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716761 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716621 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716667 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL9716644 | 1.00 | FFAR4 (0.44) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL7192321 | 0.98 | FFAR4 (0.41) | FFAR4FFAR1SLC6A5GRIK1GRIK2 | |
| SCHEMBL7192319 | 0.98 | FFAR4 (0.41) | FFAR4FFAR1SLC6A5GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | disclosed |
| EP-1264589-A1 | Use of a polar additive in a cosmetic composition containing a structured liquid oil phase by at least one organogelator to give a thixotropic character | L'OREAL (FR) | 2002-12-11 | — | — | EP | disclosed |
| US-6214329-B1 | PIGMENTED EMULSION OF NON-POLYMERIC GELLING AGENT SUCH AS N-ACYL AMINO ACIDS, ESTERS OR AMIDES, 12-HYDROXYSTEARIC ACID, ESTER, OR AMIDE, FATTY ESTERS OF POLYFUNCTIONAL ALCOHOL DIMERS, AND ALKYLAMIDES OF DI- OR TRI-CARBOXYLIC ACIDS | REVLON CONSUMER PRODUCTS CORPORATION | 2001-04-10 | — | — | US | disclosed |
| WO-2000074519-A2 | MASCARA COMPOSITIONS AND METHODS FOR CURLING LASHES | REVLON CONSUMER PRODUCTS CORPORATION (US) | 2000-12-14 | — | — | WO | disclosed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | FFAR4 256/4885FFAR1 310/4885SLC6A5 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.